Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
National Institutes of Health
Classification and identifiers
- Solicitation number
- PAR-27-119
- Assistance listing (CFDA)
- 93.172
Amount
Amount not published by the funder
Who can apply
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
About this opportunity
The Center for Inherited Disease Research (CIDR) carries out high-throughput genotyping and sequencing and supports statistical genetics services designed to 1) aid identification of genes or genetic modifications that contribute to human health and disease or 2) enhance the classification and characterization of well-phenotyped specimens by the addition of genotype or next-generation sequence data. The laboratory specializes in genomic services that cannot be efficiently carried out in individual investigator laboratories. CIDR provides the most up-to-date platforms, services, and statistical genetic support. This is an NIH-wide initiative that is administered by NHGRI. Information about current services offered can be accessed via: https://cidr.jhmi.edu .
Related opportunities
- Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)National Institutes of HealthCloses in 2 days
- The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Genomic Research CentersNational Institutes of Health
- The NIDDK Inflammatory Bowel Disease Genetics Consortium (IBDGC) Data Coordinating CenterNational Institutes of Health
- Genomic Community Resources (U24 Clinical Trials Not Allowed)National Institutes of Health
- Single Source: Institutional Development Award (IDeA) Clinical Research Resource Center (I-CRRC)National Institutes of Health
- Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)National Institutes of HealthCloses Jan 2028